initial public offerings (IPOs) trading on American exchanges

Thursday, June 10, 2021

Reneo Pharmaceuticals (RPHM) began trading on the Nasdaq on Fri 9 Apr 21

Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases.
  • Sector(s): Healthcare
  • Industry: Biotechnology
  • Full Time Employees: 36
  • Incorporated in 2014 
  • Headquartered in Irvine, California
Reneo Pharmaceuticals priced 6.25 share IPO at $15.00 per share, at the low end of the $15-17 expected range

No comments:

Post a Comment